acellular pertussis
pertussis incidence
pertussis epidemiology
cell pertussis vaccines
PERtussIS COrrelates of Protection Europe Pertussis vaccines
global burden of pertussis
registration of novel pertussis vaccines
introduction of improved pertussis vaccines
future evaluation of novel pertussis vaccine candidates
biomarkers of protection
animal challenge models
Bp colonization
durable immunity
key objectives of PERISCOPE
duration of immunity
pathogenesis of Bp infection
harmonized human
clinical trials
clinical studies
older adults
improved reactogenicity profile of aP
related disease
molecular microbiology
strong expertise
immunology
standardized assays
EFPIA partners
cutting-edge techniques
transmission
vaccinated adolescents
accelerated development
ecosystem
vulnerable infants
risk
potential impact
industrialized countries
pre
selected group
changes
bioinformatics
optimal use of vaccination strategies
technical infrastructure
series
understanding
rise
differences
increased circulation of
adaptive responses
scientific innovation
immunization
decade
humans